Executive record

Philip L. Hodges

Director at Altimmune, Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:philip-l-hodgesVersion: public-0As of: 2026-09-28

Not yet claimed8 published Claims3 sources
  • Director

Key Claims

Biography

Philip L. Hodges is Managing Partner of Redmont & Company, a private investment bank focused on investment and advisory services for emerging growth businesses in healthcare, life science and technology sectors. He joined Redmont at its inception in 1997 and was a co-founder of Private Altimmune. He currently serves as a director for several of the firm's portfolio companies.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. ALT DEF 14A director slate

    sec filing · Source published: Mar 17, 2026 · Retrieved: May 15, 2026

    Supports 6 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Board role: Board role: Director · Claim reviewed: May 15, 2026
    • Committee assignments: Committee assignments: Audit, Compensation · Claim reviewed: May 15, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Executive company: Executive at Redmont & Company · Claim reviewed: May 15, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 15, 2026

  2. Open source

    sec proxy · Source published: Mar 17, 2026 · Retrieved: Apr 24, 2026

    Supports 1 claim
    • Professional Role: Director at Altimmune, Inc. · Claim reviewed: May 15, 2026

  3. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Altimmune, Inc. · Claim reviewed: May 15, 2026